Thus, it appears that CTCFL mutations are often produced by underlying MSI or POLE or POLD1 defects in both cancers commonly associated with these defects (colorectal and endometrial) and in other cancers less commonly associated with them (melanoma). This evidence concerns the gene CTCFL and melanoma.